HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marléne Isaksson Selected Research

2-methyl-4-isothiazolin-3-one

7/2021Patch Testing With Methylchloroisothiazolinone/Methylisothiazolinone Using a New Diagnostic Mix-A Multicenter Study From the International Contact Dermatitis Research Group.
5/2020Can patch testing with methylchloroisothiazolinone/methylisothiazolinone be optimized using a new diagnostic mix? - A multicenter study from the Swedish Contact Dermatitis Research Group.
5/2017Multicenter Patch Testing With Methylisothiazolinone and Methylchloroisothiazolinone/Methylisothiazolinone Within the International Contact Dermatitis Research Group.
11/2016Allergic contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone in a medical device.
11/2016Concomitant contact allergies to formaldehyde, methylchloroisothiazolinone/methylisothiazolinone, methylisothiazolinone, and fragrance mixes I and II.
8/2015Occupational contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone through exposure to filler dust containing this preservative and with a positive patch test reaction to the dust.
8/2015Successful inhibition of allergic contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone with topical glutathione.
1/2015Methylisothiazolinone contact allergy is rising to alarming heights also in southern Sweden.
7/2014Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group.
5/2014Multicentre patch testing with methylisothiazolinone by the European Environmental and Contact Dermatitis Research Group.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marléne Isaksson Research Topics

Disease

63Hypersensitivity (Allergy)
03/2022 - 06/2002
35Dermatitis
01/2022 - 06/2002
30Allergic Contact Dermatitis
10/2022 - 04/2002
25Contact Dermatitis (Eczema, Contact)
01/2022 - 10/2002
3Chemical Burns (Chemical Burn)
09/2013 - 12/2004
1Occupational Diseases (Occupational Disease)
01/2022
1Familial Primary Pulmonary Hypertension
08/2020
1Oral Lichen Planus
11/2018
1Skin Diseases (Skin Disease)
06/2018
1Atopic Dermatitis (Atopic Eczema)
06/2018
1Impetigo (Impetigo Contagiosa)
05/2018
1Rosacea (Acne Rosacea)
05/2018
1Respiratory Tract Diseases (Respiratory Tract Disease)
04/2018
1Stomatitis
10/2017
1Perioral Dermatitis
10/2017
1Burns
09/2013

Drug/Important Bio-Agent (IBA)

19AllergensIBA
03/2022 - 06/2002
12Coloring Agents (Dyes)IBA
10/2022 - 04/2008
112-methyl-4-isothiazolin-3-oneIBA
07/2021 - 12/2004
95-chloro-2-methyl-4-isothiazolin-3-oneIBA
07/2021 - 12/2004
9Formaldehyde (Formol)FDA Link
11/2019 - 09/2010
8acrylic acid (acrylate)IBA
07/2019 - 10/2006
6NickelIBA
03/2021 - 05/2004
6IsocyanatesIBA
04/2018 - 05/2003
6MethacrylatesIBA
09/2016 - 07/2007
5Petrolatum (Vaseline)FDA Link
01/2022 - 05/2004
5Adrenal Cortex Hormones (Corticosteroids)IBA
12/2007 - 06/2002
4PlasticsIBA
01/2022 - 11/2006
4Irritants (Vesicants)IBA
01/2022 - 02/2003
4chromium hexavalent ionIBA
01/2020 - 06/2018
4AcrylatesIBA
01/2011 - 10/2006
3CobaltIBA
03/2021 - 06/2018
34-phenylenediamine (p-phenylenediamine)FDA Link
11/2020 - 02/2013
3carvoneIBA
11/2018 - 01/2014
3nickel sulfateFDA Link
06/2018 - 05/2004
3AminesIBA
10/2017 - 03/2004
3rosin (pine resin)FDA Link
09/2015 - 07/2011
3Pharmaceutical PreparationsIBA
02/2013 - 06/2002
3Epoxy ResinsFDA Link
09/2008 - 01/2004
2linaloolIBA
01/2022 - 09/2019
2SolventsIBA
01/2022 - 09/2018
2geraniol (nerol)IBA
01/2020 - 10/2018
2Glutathione (Reduced Glutathione)IBA
01/2020 - 08/2015
24,4'-diphenylmethane diisocyanate (methylene diphenyl diisocyanate)IBA
10/2017 - 02/2013
2hydroxyisohexyl 3-cyclohexene carboxaldehydeIBA
01/2017 - 03/2014
2Phenol (Carbolic Acid)FDA Link
09/2015 - 07/2011
24,4'-diaminodiphenylmethaneIBA
02/2013 - 05/2003
2Budesonide (Pulmicort)FDA LinkGeneric
01/2004 - 06/2002
1Acetates (Acetic Acid Esters)FDA Link
10/2022
1Nylons (Nylon)IBA
10/2022
1PolyestersIBA
10/2022
1HaptensIBA
03/2022
1SaltsIBA
01/2022
1Terpenes (Terpenoids)IBA
01/2022
11-phenylazo-2-naphthol (Sudan I)IBA
01/2022
1LimoneneIBA
01/2022
1Aluminum ChlorideIBA
01/2022
1AluminumIBA
01/2022
12,4-dichlorophenolIBA
12/2021
1captaxFDA Link
05/2021
1polihexanideIBA
05/2021
1polyaminopropylbiguanide (PAPB)IBA
05/2021
1ChromiumIBA
03/2021
1Tuberculin (PPD)IBA
11/2020
1isobornyl acrylateIBA
08/2020
1PalladiumIBA
04/2020
1ChromatesIBA
01/2020
1IronIBA
01/2020
1citral (neral)IBA
01/2020
1Sulfates (Sulfates, Inorganic)IBA
01/2020
11,6-hexanediol diacrylateIBA
12/2019
1Adhesives (Glues)IBA
10/2019
1DeodorantsIBA
09/2019
1Glucose (Dextrose)FDA LinkGeneric
07/2019
117- N,N- diethylcarbamoyl- 4- methyl- 4- azaandrostane- 3- one (DMAA)IBA
07/2019
1Insulin (Novolin)FDA Link
07/2019
1drometrizoleIBA
08/2018
1cobaltous chloride (cobalt(II)chloride)IBA
06/2018
1A-factor (Streptomyces)IBA
04/2018
1methylene bis(4-cyclohexylisocyanate)IBA
10/2017
1ToothpastesIBA
10/2017
1methacrylic acidIBA
02/2017
1CosmeticsIBA
03/2016
1Dispersion Yellow 3IBA
07/2015
1Amerchol L101IBA
05/2015
1Potassium DichromateFDA Link
05/2015
1quaternium-15FDA Link
07/2014
1diazolidinylurea (diazolidinyl urea)IBA
07/2014
1Dental MaterialsIBA
01/2014
1MercuryIBA
01/2014
1AcidsIBA
09/2013
1FluorineIBA
09/2013
1Hydrofluoric Acid (Hydrogen Fluoride)IBA
09/2013
1Trifluoroacetic Acid (Trifluoroacetate)IBA
09/2013
1GoldIBA
02/2013
1Proteins (Proteins, Gene)FDA Link
01/2013
1SesquiterpenesIBA
05/2011

Therapy/Procedure

2Eyeglasses (Spectacles)
01/2022 - 09/2018
1Secondary Prevention
01/2020
1Aftercare (After-Treatment)
02/2013